The increased metastatic potential of silenced Gal-3 breast cancer cells was found to be associated with an overall reduction in the tumor content of GAGs but enhanced chondroitin sulfate A and C, versican, and the matrix metalloproteinase 9 (MMP9) expressions. The gene discussed is LGALS3; the disease is breast carcinoma.